Daniel TM. The history of tuberculosis. Respir Med. 2006;100:1862–70.

Article  PubMed  Google Scholar 

Epidemiology PT. A mortal foe. Nature. 2013;502:S2-3.

Article  Google Scholar 

World Health Organization. Global Tuberculosis Report 2023. Geneva, Switzerland; 2023.

Watson HH. African learning experience. Nurs Stand. 2014;28:66–66.

Article  PubMed  Google Scholar 

Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43:1763–75.

Article  PubMed  PubMed Central  Google Scholar 

Kyu HH, Maddison ER, Henry NJ, Ledesma JR, Wiens KE, Reiner R, et al. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis. 2018;18:1329–49.

Article  Google Scholar 

Silva S, Arinaminpathy N, Atun R, Goosby E, Reid M. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis. Lancet Glob Heal. 2021;9:e1372–9.

Article  CAS  Google Scholar 

Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. The economic effects of supporting tuberculosis-affected households in Peru. Eur Respir J. 2016;48:1396–410.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Tuberculosis patient cost surveys: a handbook. 2017.

Wingfield T, Tovar MA, Huff D, Boccia D, Saunders MJ, Datta S, et al. Beyond pills and tests: addressing the social determinants of tuberculosis. Clin Med. 2016;16:s79-91.

Article  Google Scholar 

Boccia D, Bond V. The catastrophic cost of tuberculosis: advancing research and solutions. Int J Tuberc Lung Dis. 2019;23:1129–30.

Article  CAS  PubMed  Google Scholar 

World Health Organization. The End TB Strategy. Geneva, Switzerland; 2015.

World Health Organization. Global Tuberculosis Report 2022. Geneva, Switzerland; 2022.

World Health Organization. Global Tuberculosis Report 2023—Country Profile: Viet Nam. Geneva, Switzerland; 2023.

Nhung NV, Hoa NB, Anh NT, Ngoc Anh LT, Siroka A, Lönnroth K, et al. Measuring catastrophic costs due to tuberculosis in Viet Nam. Int J Tuberc Lung Dis. 2018;22:983–90.

Article  CAS  PubMed  Google Scholar 

Vo LNQ, Codlin AJ, Huynh HB, Mai TDT, Forse RJ, Van TV, et al. Enhanced private sector engagement for tuberculosis diagnosis and reporting through an intermediary agency in Ho Chi Minh City, Viet Nam. Trop Med Infect Dis. 2020;5:143.

Article  PubMed  PubMed Central  Google Scholar 

Lönnroth K, Tran TU, Thuong LM, Quy HT, Diwan V. Can I afford free treatment? Perceived consequences of health care provider choices among people with tuberculosis in Ho Chi Minh City, Vietnam. Soc Sci Med. 2001;52:935–48.

Article  PubMed  Google Scholar 

Lönnroth K, Thuong LM, Lambregts K, Quy HT, Diwan VK. Private tuberculosis care provision associated with poor treatment outcome: comparative study of a semi-private lung clinic and the NTP in two urban districts in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis. 2003;7:165–71.

PubMed  Google Scholar 

Courtwright A, Turner AN. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010;125(SUPPL. 4):34–42.

Article  PubMed  PubMed Central  Google Scholar 

Nhassengo P, Yoshino C, Zandamela A, De Carmo V, Burström B, Lönnroth K, et al. ‘They didn’t look at me with good eyes’–experiences of the socioeconomic impact of tuberculosis and support needs among adults in a semi-rural area in Mozambique: a qualitative study. Glob Public Health. 2024;19:2311682.

Article  PubMed  Google Scholar 

Hof S, Najilis C, Bloss E, Straetemans M. A systematic review on the role of gender in tuberculosis control. Adv Med Sci. 2010;63:1–2.

Google Scholar 

Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med. 2006;11:353–63.

Article  PubMed  Google Scholar 

Hanson C, Osberg M, Brown J, Durham G, Chin DP. Finding the missing patients with tuberculosis: lessons learned from patient-pathway analyses in 5 countries. J Infect Dis. 2017;216:S686–95.

Article  PubMed  PubMed Central  Google Scholar 

Lönnroth K, Thuong LM, Linh PD, Diwan V. Risks and benefits of private health care: exploring physicians’ views on private health care in Ho Chi Minh City, Vietnam. Health Policy. 1998;45:81–97.

Article  PubMed  Google Scholar 

Viet Nam National TB Control Programme. Measuring the level of under-reporting and estimating incidence for tuberculosis in Viet Nam: preliminary results TB Inventory Study 2016–2017. In: Workshop Report January. Ha Noi; 2018.

Nguyen MP, Tariq A, Hinchcliff R, Luu HN, Dunne MP. Contribution of private health services to universal health coverage in low and middle-income countries: factors affecting the use of private over public health services in Vietnam. Int J Health Plann Manage. 2023;38:1613–28.

Article  PubMed  Google Scholar 

Vo LNQ, Forse RJ, Codlin AJ, Dang HM, Van Truong V, Nguyen LH, et al. Socio-protective effects of active case finding on catastrophic costs from tuberculosis in Ho Chi Minh City, Viet Nam: a longitudinal patient cost survey. BMC Health Serv Res. 2021;21:1051.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Viet Nam COVID-19 Situation Report # 108. Ha Noi, Viet Nam; 2023.

Kirubi B, Ongango J, Nguhiu P, Lönnroth K, Rono A, Sidney-Annerstedt K. Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya. Infect Dis Poverty. 2021;10:95.

Article  PubMed  PubMed Central  Google Scholar 

Kilale AM, Pantoja A, Jani B, Range N, Ngowi BJ, Makasi C, et al. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households. BMC Public Health. 2022;22:600.

Article  PubMed  PubMed Central  Google Scholar 

Stracker N, Hanrahan C, Mmolawa L, Nonyane B, Tampi R, Tucker A, et al. Risk factors for catastrophic costs associated with tuberculosis in rural South Africa. Int J Tuberc Lung Dis. 2019;23:756–63.

Article  CAS  PubMed  Google Scholar 

Nhung NV, Hoa NB, Anh NT, Anh LTN, Siroka A, Lönnroth K, et al. Measuring catastrophic costs due to tuberculosis in Viet Nam. Int J Tuberc Lung Dis. 2018;22:983–90.

Article  CAS  PubMed  Google Scholar 

Dinh LV, Wiemers AMC, Forse RJ, Phan YTH, Codlin AJ, Annerstedt KS, et al. Comparing catastrophic costs: active vs. passive tuberculosis case finding in urban Vietnam. Trop Med Infect Dis. 2023;8:423.

Article  PubMed  PubMed Central  Google Scholar 

Fuady A, Houweling TAJ, Mansyur M, Richardus JH. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia’s implementation of universal health coverage. Infect Dis Poverty. 2018;7:3.

Article  PubMed  PubMed Central  Google Scholar 

Muniyandi M, Thomas BE, Karikalan N, Kannan T, Rajendran K, Saravanan B, et al. Association of tuberculosis with household catastrophic expenditure in South India. JAMA Netw open. 2020;3: e1920973.

Article  PubMed  Google Scholar 

Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Heal Organ. 2017;95:270–80.

Article  Google Scholar 

Ministry of Interior Affairs. Approval of the bylaws and to establish the Patient Support Foundation to end TB (PASTB). Viet Nam; 2018.

Nguyen HB, Nguyen NV. National tuberculosis patients cost survey: research findings lead to change in policy and practice, Viet Nam. Public Heal Action. 2019;9:50–2.

Article  Google Scholar 

Vo LNQ, Forse RJ, Codlin AJ, Vu TN, Le GT, Do GC, et al. A comparative impact evaluation of two human resource models for community-based active tuberculosis case finding in Ho Chi Minh City, Viet Nam. BMC Public Health. 2020;20:934.

Article  PubMed  PubMed Central  Google Scholar 

Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, et al. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Glob Heal. 2017;5:e1123–32.

Article  Google Scholar 

McLaren ZM, Milliken AA, Meyer AJ, Sharp AR. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy. BMC Infect Dis. 2016;16:537.

Article  PubMed  PubMed Central  Google Scholar 

Cremers AL, Gerrets R, Kapata N, Kabika A, Birnie E, Klipstein-Grobusch K, et al. Tuberculosis patients’ pre-hospital delay and non-compliance with a longstanding DOT programme: a mixed methods study in urban Zambia. BMC Public Health. 2016;16:1130.

Article  PubMed  PubMed Central  Google Scholar 

Stop TB Partnership. The Global Plan to End TB 2023-2030. Geneva, Switzerland; 2022.

Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC): Diagnosis, treatment, public health. 2006.

World Health Organization. What is DOTS? A Guide to Understanding the WHO-recommended TB Control Strategy Known as DOTS. Geneva, Switzerland; 1999.

Zimmer AJ, Heitkamp P, Malar J, Dantas C, O’Brien K, Pandita A, et al. Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: a community perspective. J Clin Tuberc Other Mycobact Dis. 2021;24: 100248.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Philip S, Isaakidis P, Sagili KD, Meharunnisa A, Mrithyunjayan S, Kumar AMV. “They know, they agree, but they don’t do”—the paradox of tuberculosis case notification by private practitioners in Alappuzha district, Kerala, India. PLoS ONE. 2015;10:1–13.

Article  Google Scholar 

Mahendradhata Y. The case for stronger regulation of private practitioners to control tuberculosis in low- and middle-income countries Infectious Diseases. BMC Res Notes. 2015;8:600.

Article  PubMed  PubMed Central  Google Scholar